25 XP   0   0   10

Immutep Ltd
Buy, Hold or Sell?

Let's analyse Immutep together

PenkeI guess you are interested in Immutep Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Immutep Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Immutep Ltd

I send you an email if I find something interesting about Immutep Ltd.

Quick analysis of Immutep (30 sec.)










What can you expect buying and holding a share of Immutep? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.11
Expected worth in 1 year
A$0.26
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
A$0.14
Return On Investment
40.2%

For what price can you sell your share?

Current Price per Share
A$0.36
Expected price per share
A$0.3 - A$0.4175
How sure are you?
50%

1. Valuation of Immutep (5 min.)




Live pricePrice per Share (EOD)

A$0.36

Intrinsic Value Per Share

A$-0.43 - A$-0.19

Total Value Per Share

A$-0.32 - A$-0.07

2. Growth of Immutep (5 min.)




Is Immutep growing?

Current yearPrevious yearGrowGrow %
How rich?$87.6m$60.4m$27.2m31.1%

How much money is Immutep making?

Current yearPrevious yearGrowGrow %
Making money-$25.6m-$20.6m-$4.9m-19.3%
Net Profit Margin-1,138.0%-18,906.5%--

How much money comes from the company's main activities?

3. Financial Health of Immutep (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#403 / 1016

Most Revenue
#433 / 1016

Most Profit
#754 / 1016

Most Efficient
#820 / 1016

What can you expect buying and holding a share of Immutep? (5 min.)

Welcome investor! Immutep's management wants to use your money to grow the business. In return you get a share of Immutep.

What can you expect buying and holding a share of Immutep?

First you should know what it really means to hold a share of Immutep. And how you can make/lose money.

Speculation

The Price per Share of Immutep is A$0.355. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Immutep.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Immutep, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.11. Based on the TTM, the Book Value Change Per Share is A$0.04 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Immutep.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-6.1%-0.02-6.1%-0.02-4.9%-0.01-4.1%-0.01-4.0%
Usd Book Value Change Per Share0.026.5%0.026.5%0.013.2%0.013.1%0.011.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.026.5%0.026.5%0.013.2%0.013.1%0.011.6%
Usd Price Per Share0.20-0.20-0.19-0.17-0.10-
Price to Earnings Ratio-9.39--9.39--10.70--11.45--7.04-
Price-to-Total Gains Ratio8.83-8.83-16.57-11.84-9.38-
Price to Book Ratio2.74-2.74-3.66-4.42-3.10-
Price-to-Total Gains Ratio8.83-8.83-16.57-11.84-9.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2280165
Number of shares4385
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.020.01
Gains per Quarter (4385 shares)100.4348.78
Gains per Year (4385 shares)401.73195.12
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104023920195185
208037940390380
30120511960585575
40160715980780770
50200920000976965
6024102402011711160
7028122804013661355
8032143206015611550
9036163608017561745
10040174010019511940

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.016.08.00.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%7.03.00.070.0%14.010.00.058.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.024.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%7.03.00.070.0%14.010.00.058.3%

Fundamentals of Immutep

About Immutep Ltd

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Its LAG-3 immunotherapies are designed to harness and strengthen the power of patients' immune systems to fight cancer and autoimmune disease. Its lead product candidate is eftilagimod alpha (efti or IMP321) for the treatment of different types of cancers. The trials that efi is being evaluated in include TACTI-002, a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC); TACTI-003, a Phase IIb clinical trial to treat HNSCC; and INSIGHT-003, a Phase I clinical trial for the treatment of NSCLC, as well as INSIGHT-005, a Phase I/IIa clinical trial to treat solid tumors. In addition, it offers IMP761, an agonist of lymphocyte activation gene 3 for autoimmune disease; IMP701, an antagonist antibody that acts to stimulate T cell proliferation in cancer patients; and IMP731, a depleting antibody that removes T cells involved in autoimmunity. The company has collaboration agreements with GlaxoSmithKline, Novartis, CYTLIMIC Inc., Merck & Co., Inc., Institute of Clinical Cancer Research, Merck KGaA, and EOC Pharma. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-03-31 22:05:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Immutep Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Immutep earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Immutep to the Biotechnology industry mean.
  • A Net Profit Margin of -1,138.0% means that $-11.38 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Immutep Ltd:

  • The MRQ is -1,138.0%. The company is making a huge loss. -2
  • The TTM is -1,138.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,138.0%TTM-1,138.0%0.0%
TTM-1,138.0%YOY-18,906.5%+17,768.5%
TTM-1,138.0%5Y-6,527.7%+5,389.7%
5Y-6,527.7%10Y-7,150.0%+622.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,138.0%-199.6%-938.4%
TTM-1,138.0%-213.0%-925.0%
YOY-18,906.5%-279.3%-18,627.2%
5Y-6,527.7%-438.4%-6,089.3%
10Y-7,150.0%-605.5%-6,544.5%
1.1.2. Return on Assets

Shows how efficient Immutep is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Immutep to the Biotechnology industry mean.
  • -27.1% Return on Assets means that Immutep generated $-0.27 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Immutep Ltd:

  • The MRQ is -27.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -27.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.1%TTM-27.1%0.0%
TTM-27.1%YOY-31.5%+4.5%
TTM-27.1%5Y-32.8%+5.8%
5Y-32.8%10Y-52.0%+19.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.1%-13.5%-13.6%
TTM-27.1%-12.9%-14.2%
YOY-31.5%-11.8%-19.7%
5Y-32.8%-14.1%-18.7%
10Y-52.0%-16.0%-36.0%
1.1.3. Return on Equity

Shows how efficient Immutep is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Immutep to the Biotechnology industry mean.
  • -29.2% Return on Equity means Immutep generated $-0.29 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Immutep Ltd:

  • The MRQ is -29.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -29.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.2%TTM-29.2%0.0%
TTM-29.2%YOY-34.2%+5.0%
TTM-29.2%5Y-42.3%+13.1%
5Y-42.3%10Y-65.0%+22.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.2%-16.9%-12.3%
TTM-29.2%-16.1%-13.1%
YOY-34.2%-15.1%-19.1%
5Y-42.3%-19.9%-22.4%
10Y-65.0%-20.9%-44.1%

1.2. Operating Efficiency of Immutep Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Immutep is operating .

  • Measures how much profit Immutep makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Immutep to the Biotechnology industry mean.
  • An Operating Margin of -1,281.8% means the company generated $-12.82  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Immutep Ltd:

  • The MRQ is -1,281.8%. The company is operating very inefficient. -2
  • The TTM is -1,281.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,281.8%TTM-1,281.8%0.0%
TTM-1,281.8%YOY-19,920.0%+18,638.2%
TTM-1,281.8%5Y-7,305.8%+6,023.9%
5Y-7,305.8%10Y-7,619.5%+313.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,281.8%-295.1%-986.7%
TTM-1,281.8%-225.8%-1,056.0%
YOY-19,920.0%-288.4%-19,631.6%
5Y-7,305.8%-477.4%-6,828.4%
10Y-7,619.5%-625.6%-6,993.9%
1.2.2. Operating Ratio

Measures how efficient Immutep is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 12.82 means that the operating costs are $12.82 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Immutep Ltd:

  • The MRQ is 12.818. The company is inefficient in keeping operating costs low. -1
  • The TTM is 12.818. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ12.818TTM12.8180.000
TTM12.818YOY211.724-198.906
TTM12.8185Y98.306-85.488
5Y98.30610Y92.708+5.599
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.8183.090+9.728
TTM12.8183.264+9.554
YOY211.7243.783+207.941
5Y98.3065.679+92.627
10Y92.7087.894+84.814

1.3. Liquidity of Immutep Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Immutep is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 13.81 means the company has $13.81 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Immutep Ltd:

  • The MRQ is 13.811. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.811. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ13.811TTM13.8110.000
TTM13.811YOY14.157-0.346
TTM13.8115Y10.897+2.915
5Y10.89710Y9.343+1.554
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.8113.914+9.897
TTM13.8114.220+9.591
YOY14.1575.388+8.769
5Y10.8976.045+4.852
10Y9.3436.406+2.937
1.3.2. Quick Ratio

Measures if Immutep is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Immutep to the Biotechnology industry mean.
  • A Quick Ratio of 13.45 means the company can pay off $13.45 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Immutep Ltd:

  • The MRQ is 13.445. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.445. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ13.445TTM13.4450.000
TTM13.445YOY13.776-0.331
TTM13.4455Y10.515+2.931
5Y10.51510Y9.284+1.231
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.4453.572+9.873
TTM13.4453.998+9.447
YOY13.7765.390+8.386
5Y10.5155.969+4.546
10Y9.2846.287+2.997

1.4. Solvency of Immutep Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Immutep assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Immutep to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.07 means that Immutep assets are financed with 7.4% credit (debt) and the remaining percentage (100% - 7.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Immutep Ltd:

  • The MRQ is 0.074. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.074. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.074TTM0.0740.000
TTM0.074YOY0.079-0.005
TTM0.0745Y0.189-0.114
5Y0.18910Y0.196-0.007
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0740.336-0.262
TTM0.0740.334-0.260
YOY0.0790.269-0.190
5Y0.1890.366-0.177
10Y0.1960.390-0.194
1.4.2. Debt to Equity Ratio

Measures if Immutep is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Immutep to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.0% means that company has $0.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Immutep Ltd:

  • The MRQ is 0.080. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.080. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.080TTM0.0800.000
TTM0.080YOY0.086-0.006
TTM0.0805Y0.270-0.189
5Y0.27010Y0.265+0.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0800.382-0.302
TTM0.0800.396-0.316
YOY0.0860.335-0.249
5Y0.2700.434-0.164
10Y0.2650.465-0.200

2. Market Valuation of Immutep Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Immutep generates.

  • Above 15 is considered overpriced but always compare Immutep to the Biotechnology industry mean.
  • A PE ratio of -9.39 means the investor is paying $-9.39 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Immutep Ltd:

  • The EOD is -10.578. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.386. Based on the earnings, the company is expensive. -2
  • The TTM is -9.386. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.578MRQ-9.386-1.192
MRQ-9.386TTM-9.3860.000
TTM-9.386YOY-10.703+1.317
TTM-9.3865Y-11.452+2.065
5Y-11.45210Y-7.038-4.413
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.578-2.259-8.319
MRQ-9.386-2.569-6.817
TTM-9.386-2.664-6.722
YOY-10.703-4.120-6.583
5Y-11.452-6.258-5.194
10Y-7.038-6.171-0.867
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Immutep Ltd:

  • The EOD is -11.746. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.423. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.423. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.746MRQ-10.423-1.323
MRQ-10.423TTM-10.4230.000
TTM-10.423YOY-11.396+0.974
TTM-10.4235Y-15.552+5.130
5Y-15.55210Y-10.358-5.194
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-11.746-2.924-8.822
MRQ-10.423-3.246-7.177
TTM-10.423-3.488-6.935
YOY-11.396-5.620-5.776
5Y-15.552-8.315-7.237
10Y-10.358-8.826-1.532
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Immutep is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.74 means the investor is paying $2.74 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Immutep Ltd:

  • The EOD is 3.093. Based on the equity, the company is fair priced.
  • The MRQ is 2.744. Based on the equity, the company is underpriced. +1
  • The TTM is 2.744. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.093MRQ2.744+0.348
MRQ2.744TTM2.7440.000
TTM2.744YOY3.665-0.921
TTM2.7445Y4.417-1.673
5Y4.41710Y3.096+1.321
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.0931.851+1.242
MRQ2.7442.090+0.654
TTM2.7442.095+0.649
YOY3.6652.844+0.821
5Y4.4173.466+0.951
10Y3.0963.815-0.719
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Immutep Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Immutep Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0360.0360%0.018+104%0.017+106%0.009+295%
Book Value Per Share--0.1150.1150%0.079+45%0.061+89%0.042+171%
Current Ratio--13.81113.8110%14.157-2%10.897+27%9.343+48%
Debt To Asset Ratio--0.0740.0740%0.079-6%0.189-61%0.196-62%
Debt To Equity Ratio--0.0800.0800%0.086-6%0.270-70%0.265-70%
Dividend Per Share----0%-0%-0%-0%
Eps---0.034-0.0340%-0.027-19%-0.023-33%-0.022-34%
Free Cash Flow Per Share---0.030-0.0300%-0.025-16%-0.019-39%-0.013-56%
Free Cash Flow To Equity Per Share--0.0340.0340%0.017+100%0.016+106%0.009+265%
Gross Profit Margin--1.1351.1350%1.000+14%1.027+11%1.014+12%
Intrinsic Value_10Y_max---0.188--------
Intrinsic Value_10Y_min---0.433--------
Intrinsic Value_1Y_max---0.015--------
Intrinsic Value_1Y_min---0.029--------
Intrinsic Value_3Y_max---0.047--------
Intrinsic Value_3Y_min---0.100--------
Intrinsic Value_5Y_max---0.084--------
Intrinsic Value_5Y_min---0.184--------
Market Cap422034632.960+11%374481434.880374481434.8800%344760686.080+9%317417597.184+18%182842046.618+105%
Net Profit Margin---11.380-11.3800%-189.065+1561%-65.277+474%-71.500+528%
Operating Margin---12.818-12.8180%-199.200+1454%-73.058+470%-76.195+494%
Operating Ratio--12.81812.8180%211.724-94%98.306-87%92.708-86%
Pb Ratio3.093+11%2.7442.7440%3.665-25%4.417-38%3.096-11%
Pe Ratio-10.578-13%-9.386-9.3860%-10.703+14%-11.452+22%-7.038-25%
Price Per Share0.355+11%0.3150.3150%0.290+9%0.267+18%0.154+105%
Price To Free Cash Flow Ratio-11.746-13%-10.423-10.4230%-11.396+9%-15.552+49%-10.358-1%
Price To Total Gains Ratio9.956+11%8.8348.8340%16.570-47%11.837-25%9.382-6%
Quick Ratio--13.44513.4450%13.776-2%10.515+28%9.284+45%
Return On Assets---0.271-0.2710%-0.315+17%-0.328+21%-0.520+92%
Return On Equity---0.292-0.2920%-0.342+17%-0.423+45%-0.650+122%
Total Gains Per Share--0.0360.0360%0.018+104%0.017+106%0.009+295%
Usd Book Value--87654288.55587654288.5550%60425892.182+45%46438987.152+89%32382147.728+171%
Usd Book Value Change Per Share--0.0230.0230%0.011+104%0.011+106%0.006+295%
Usd Book Value Per Share--0.0740.0740%0.051+45%0.039+89%0.027+171%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.022-0.0220%-0.017-19%-0.014-33%-0.014-34%
Usd Free Cash Flow---23077839.000-23077839.0000%-19431287.372-16%-14133827.943-39%-10265900.426-56%
Usd Free Cash Flow Per Share---0.019-0.0190%-0.016-16%-0.012-39%-0.009-56%
Usd Free Cash Flow To Equity Per Share--0.0220.0220%0.011+100%0.011+106%0.006+265%
Usd Market Cap271072844.750+11%240529425.623240529425.6230%221439788.669+9%203877322.671+18%117439446.542+105%
Usd Price Per Share0.228+11%0.2020.2020%0.186+9%0.171+18%0.099+105%
Usd Profit---25625424.320-25625424.3200%-20689013.540-19%-16924434.277-34%-16787933.708-34%
Usd Revenue--2251725.2412251725.2410%109428.009+1958%1948111.701+16%1654974.523+36%
Usd Total Gains Per Share--0.0230.0230%0.011+104%0.011+106%0.006+295%
 EOD+6 -2MRQTTM+0 -0YOY+22 -125Y+24 -1010Y+26 -8

4.2. Fundamental Score

Let's check the fundamental score of Immutep Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.578
Price to Book Ratio (EOD)Between0-13.093
Net Profit Margin (MRQ)Greater than0-11.380
Operating Margin (MRQ)Greater than0-12.818
Quick Ratio (MRQ)Greater than113.445
Current Ratio (MRQ)Greater than113.811
Debt to Asset Ratio (MRQ)Less than10.074
Debt to Equity Ratio (MRQ)Less than10.080
Return on Equity (MRQ)Greater than0.15-0.292
Return on Assets (MRQ)Greater than0.05-0.271
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Immutep Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.760
Ma 20Greater thanMa 500.379
Ma 50Greater thanMa 1000.370
Ma 100Greater thanMa 2000.354
OpenGreater thanClose0.350
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets147,449
Total Liabilities10,980
Total Stockholder Equity136,469
 As reported
Total Liabilities 10,980
Total Stockholder Equity+ 136,469
Total Assets = 147,449

Assets

Total Assets147,449
Total Current Assets134,965
Long-term Assets12,484
Total Current Assets
Cash And Cash Equivalents 123,418
Net Receivables 7,973
Other Current Assets 3,574
Total Current Assets  (as reported)134,965
Total Current Assets  (calculated)134,965
+/-0
Long-term Assets
Property Plant Equipment 469
Goodwill 110
Intangible Assets 9,380
Long-term Assets Other 2,525
Long-term Assets  (as reported)12,484
Long-term Assets  (calculated)12,484
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities9,772
Long-term Liabilities1,207
Total Stockholder Equity136,469
Total Current Liabilities
Short-term Debt 185
Accounts payable 5,448
Other Current Liabilities 4,139
Total Current Liabilities  (as reported)9,772
Total Current Liabilities  (calculated)9,772
+/-0
Long-term Liabilities
Long term Debt Total 1,043
Other Liabilities 164
Long-term Liabilities  (as reported)1,207
Long-term Liabilities  (calculated)1,207
+/- 0
Total Stockholder Equity
Common Stock446,272
Retained Earnings -339,931
Accumulated Other Comprehensive Income 30,128
Total Stockholder Equity (as reported)136,469
Total Stockholder Equity (calculated)136,469
+/-0
Other
Capital Stock446,272
Cash And Equivalents3,588
Cash and Short Term Investments 123,418
Common Stock Shares Outstanding 880,213
Liabilities and Stockholders Equity 147,449
Net Debt -122,189
Net Invested Capital 137,305
Net Tangible Assets 126,979
Net Working Capital 125,193
Property Plant and Equipment Gross 1,113
Short Long Term Debt Total 1,228



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
> Total Assets 
2,095
4,244
5,926
3,968
5,768
9,131
7,360
4,358
2,821
2,490
19,011
57,641
41,613
32,814
25,378
30,983
42,554
34,964
46,999
40,541
46,597
82,031
102,170
147,449
147,449102,17082,03146,59740,54146,99934,96442,55430,98325,37832,81441,61357,64119,0112,4902,8214,3587,3609,1315,7683,9685,9264,2442,095
   > Total Current Assets 
0
0
0
0
0
0
0
0
1,181
1,373
16,774
57,063
40,903
31,808
24,684
8,023
21,671
15,919
28,643
23,542
31,152
68,419
90,812
134,965
134,96590,81268,41931,15223,54228,64315,91921,6718,02324,68431,80840,90357,06316,7741,3731,18100000000
       Cash And Cash Equivalents 
687
2,992
3,715
1,579
2,785
7,533
3,211
672
1,109
951
15,641
45,931
17,005
22,023
14,200
6,760
20,880
12,237
23,476
16,568
26,322
60,128
79,995
123,418
123,41879,99560,12826,32216,56823,47612,23720,8806,76014,20022,02317,00545,93115,6419511,1096723,2117,5332,7851,5793,7152,992687
       Short-term Investments 
0
50
0
0
0
0
0
0
0
0
10,000
10,000
21,045
8,000
9,000
0
0
0
0
0
0
0
0
0
0000000009,0008,00021,04510,00010,00000000000500
       Net Receivables 
118
149
34
66
603
77
112
33
71
357
428
420
793
357
362
861
169
2,194
3,482
5,231
3,392
6,124
8,374
7,973
7,9738,3746,1243,3925,2313,4822,1941698613623577934204283577133112776036634149118
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
214
192
0
0
0
0
0
0
0
0
465
-1,108
0
0-1,1084650000000019221400000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
1,640
1,116
2,237
578
710
1,006
694
22,960
20,883
19,045
18,356
17,000
15,445
13,611
11,358
12,484
12,48411,35813,61115,44517,00018,35619,04520,88322,9606941,0067105782,2371,1161,64000000000
       Property Plant Equipment 
1,265
9
63
67
61
47
51
47
30
19
97
120
484
835
577
298
32
24
26
53
251
310
308
469
4693083102515326243229857783548412097193047514761676391,265
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
110
110
110
110
110
110
110
110
110
110110110110110110110110110000000000000000
       Intangible Assets 
0
1,044
2,055
2,256
2,299
1,266
668
626
584
542
500
458
226
171
117
22,552
20,742
18,910
18,219
16,837
15,085
12,737
10,444
9,380
9,38010,44412,73715,08516,83718,21918,91020,74222,5521171712264585005425846266681,2662,2992,2562,0551,0440
       Other Assets 
0
0
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
454
496
2,525
2,5254964540000000000000000005000
> Total Liabilities 
219
102
466
875
641
788
1,043
278
188
677
2,224
2,542
4,455
3,566
2,786
6,294
7,237
8,431
13,477
16,154
13,298
8,759
8,092
10,980
10,9808,0928,75913,29816,15413,4778,4317,2376,2942,7863,5664,4552,5422,2246771882781,043788641875466102219
   > Total Current Liabilities 
189
101
466
873
638
775
1,026
261
188
677
2,223
2,537
4,444
3,560
2,771
4,380
1,472
2,632
3,853
5,299
3,364
5,340
6,414
9,772
9,7726,4145,3403,3645,2993,8532,6321,4724,3802,7713,5604,4442,5372,2236771882611,026775638873466101189
       Short-term Debt 
0
0
0
0
0
0
0
0
0
240
700
10,000
21,045
8,000
9,000
1,508
0
5,779
6,646
0
129
208
173
185
18517320812906,6465,77901,5089,0008,00021,04510,000700240000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,508
0
5,779
6,646
0
0
0
0
0
000006,6465,77901,508000000000000000
       Accounts payable 
164
0
466
191
288
378
409
122
119
116
1,352
1,770
2,724
3,087
2,217
2,202
561
1,139
1,615
2,557
1,640
1,825
2,866
5,448
5,4482,8661,8251,6402,5571,6151,1395612,2022,2173,0872,7241,7701,3521161191224093782881914660164
       Other Current Liabilities 
25
101
0
682
349
396
617
139
69
321
171
767
1,720
473
554
669
911
1,493
2,238
2,742
1,595
3,307
3,375
4,139
4,1393,3753,3071,5952,7422,2381,4939116695544731,72076717132169139617396349682010125
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
1
4
10
6
15
1,914
5,765
5,799
9,623
10,855
9,934
3,419
1,678
1,207
1,2071,6783,4199,93410,8559,6235,7995,7651,91415610410000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,027
5,779
6,646
7,643
8,922
2,607
1,560
1,043
1,0431,5602,6078,9227,6436,6465,7795,0270000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
-240
-700
-10,000
-21,045
-8,000
-9,000
-1,508
0
-5,779
-6,646
0
133
80
235
208
208235801330-6,646-5,7790-1,508-9,000-8,000-21,045-10,000-700-240000000000
> Total Stockholder Equity
1,876
3,131
4,337
3,093
5,066
8,343
6,316
4,080
2,633
1,813
16,788
55,099
37,158
29,248
22,592
24,690
35,318
26,532
33,522
24,388
33,299
73,272
94,077
136,469
136,46994,07773,27233,29924,38833,52226,53235,31824,69022,59229,24837,15855,09916,7881,8132,6334,0806,3168,3435,0663,0934,3373,1311,876
   Retained Earnings -339,931-302,335-274,642-275,706-262,238-244,585-231,839-222,472-160,456-128,305-114,961-99,736-79,795-50,957-38,798-35,85200000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
-1,955
-1,955
-8
-1
181
1,883
1,883
5,268
63,258
63,019
64,874
65,534
66,015
34,492
29,005
30,128
30,12829,00534,49266,01565,53464,87463,01963,2585,2681,8831,883181-1-8-1,955-1,95500000000
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue3,506
Cost of Revenue-2,062
Gross Profit1,4441,444
 
Operating Income (+$)
Gross Profit1,444
Operating Expense-42,875
Operating Income-44,937-41,431
 
Operating Expense (+$)
Research Development28,793
Selling General Administrative8,680
Selling And Marketing Expenses5,402
Operating Expense42,87542,875
 
Net Interest Income (+$)
Interest Income735
Interest Expense-20
Other Finance Cost-204
Net Interest Income919
 
Pretax Income (+$)
Operating Income-44,937
Net Interest Income919
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-39,896-49,978
EBIT - interestExpense = -44,957
-39,896
-39,876
Interest Expense20
Earnings Before Interest and Taxes (EBIT)-44,937-39,876
Earnings Before Interest and Taxes (EBITDA)-42,875
 
After tax Income (+$)
Income Before Tax-39,896
Tax Provision-0
Net Income From Continuing Ops-39,896-39,896
Net Income-39,896
Net Income Applicable To Common Shares-39,896
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses44,937
Total Other Income/Expenses Net5,041-919
 

Technical Analysis of Immutep
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Immutep. The general trend of Immutep is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Immutep's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Immutep Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.355 < 0.365 < 0.4175.

The bearish price targets are: 0.325 > 0.32 > 0.3.

Tweet this
Immutep Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Immutep Ltd. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Immutep Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Immutep Ltd. The current macd is -0.00458334.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Immutep price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Immutep. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Immutep price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Immutep Ltd Daily Moving Average Convergence/Divergence (MACD) ChartImmutep Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Immutep Ltd. The current adx is 17.99.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Immutep shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Immutep Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Immutep Ltd. The current sar is 0.40777801.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Immutep Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Immutep Ltd. The current rsi is 41.76. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Immutep Ltd Daily Relative Strength Index (RSI) ChartImmutep Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Immutep Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Immutep price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Immutep Ltd Daily Stochastic Oscillator ChartImmutep Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Immutep Ltd. The current cci is -137.03703704.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Immutep Ltd Daily Commodity Channel Index (CCI) ChartImmutep Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Immutep Ltd. The current cmo is -26.48689925.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Immutep Ltd Daily Chande Momentum Oscillator (CMO) ChartImmutep Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Immutep Ltd. The current willr is -83.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Immutep Ltd Daily Williams %R ChartImmutep Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Immutep Ltd.

Immutep Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Immutep Ltd. The current atr is 0.01542321.

Immutep Ltd Daily Average True Range (ATR) ChartImmutep Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Immutep Ltd. The current obv is -24,354,263.

Immutep Ltd Daily On-Balance Volume (OBV) ChartImmutep Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Immutep Ltd. The current mfi is 40.17.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Immutep Ltd Daily Money Flow Index (MFI) ChartImmutep Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Immutep Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Immutep Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Immutep Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.760
Ma 20Greater thanMa 500.379
Ma 50Greater thanMa 1000.370
Ma 100Greater thanMa 2000.354
OpenGreater thanClose0.350
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Immutep with someone you think should read this too:
  • Are you bullish or bearish on Immutep? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Immutep? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Immutep Ltd

I send you an email if I find something interesting about Immutep Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Immutep Ltd.

Receive notifications about Immutep Ltd in your mailbox!